Goldfinch BioPharma Patents – Insights & Stats (Updated 2023)

Goldfinch BioPharma has a total of 107 patents globally, out of which 3 have been granted. Of these 107 patents, more than 76% patents are active. Europe (EPO) & Australia is where Goldfinch BioPharma has filed the maximum number of patents, followed by Canada and Japan. Parallelly, the USA seems to be the main focused R&D center of Goldfinch BioPharma and is also the origin country of the firm.

Goldfinch BioPharma was founded in the year 2015. Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.

Do read about some of the most popular patents of Goldfinch BioPharma which have been covered by us in this article and also you can find Goldfinch BioPharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Goldfinch BioPharma patent portfolio.

How many patents does Goldfinch BioPharma have?

Goldfinch BioPharma has a total of 107 patents globally. These patents belong to 17 unique patent families. Out of 107 patents, 82 patents are active.

How Many Patents did Goldfinch BioPharma File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.  

Year of Patents Filing or Grant Goldfinch BioPharma Applications Filed Goldfinch BioPharma Patents Granted
2022 6 2
2021 21
2020 45 1
2019 22
2018 7
2017
2016
2015 5

How many Goldfinch BioPharma patents are Alive/Dead?

Worldwide Patents

How Many Patents did Goldfinch BioPharma File in Different Countries?

Countries in which Goldfinch BioPharma Filed Patents

Country Patents
Europe 11
Australia 11
Canada 10
Japan 9
Mexico 6
Singapore 5
Israel 5
Brazil 5
South Africa 5
Hong Kong (S.A.R.) 3
New Zealand 3
Taiwan 2
India 2
Indonesia 2
Argentina 2
United States Of America 2
Ecuador 1
Colombia 1
Uruguay 1
Chile 1
Pakistan 1
Viet Nam 1
Peru 1
Paraguay 1
Philippines 1
Malaysia 1

Where are Research Centres of Goldfinch BioPharma Patents Located?

What are Goldfinch BioPharma key innovation segments?

What Technologies are Covered by Goldfinch BioPharma?

The chart below distributes patents filed by Goldfinch BioPharma in different countries on the basis of the technology protected in patents. It also represents the markets where Goldfinch BioPharma thinks it’s important to protect particular technology inventions.

R&D Focus: How has Goldfinch BioPharma search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Goldfinch BioPharma?

Related Articles

Garena Patents – Insights & Stats (Updated 2024)

Garena has a total of 96 patents globally, out of which 15 have been granted. Of these 96 patents, more than 80% patents are active. Singapore is where Garena has filed the maximum number of patents, followed by United States of America and China. Parallelly, Singapore seems to be the

Read More »

Flexxon Patents – Insights & Stats (Updated 2024)

Flexxon has a total of 68 patents globally, out of which 39 have been granted. Of these 68 patents, more than 89% patents are active. Singapore is where Flexxon has filed the maximum number of patents, followed by United States of America and Australia. Parallelly, Singaporeseems to be the main

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.